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Abstract The aim of this study was to investigate central
sensitization (CS) in chronic headaches and compare this
phenomenon between chronic migraine (CM) and chronic
tension-type headache (CTTH). We recruited 69 patients
with chronic headaches and 18 control subjects. Ques-
tionnaires of headache history, allodynia and the Hospital
Anxiety and Depression scale were administered. We
recorded thresholds for pinprick and pressure pain, blink
(BR) and nociceptive flexion reflex (NFR) R3 component
coupled with wind-up ratios. Thresholds for pressure and
pinprick pain, BR and NFR R3 were lower and wind-up
ratios higher in patients. No differences of CS parameters
between CM and CTTH were observed. CS is persistent
and prevalent in patients with various types of chronic
headache. CS levels are unrelated to the predominant side
of pain, disease duration or depression. Neither is CS
related to the headache type, suggesting similar mecha-
nisms of headache chronification and chronicity
maintaining and possibly explaining clinical similarity of
various forms of chronic headache.
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Introduction
Approximately 3–5% of the population and up to 70–80%
of patients presenting to headache clinics have daily or near
daily headache [1]. The disorder is associated with sub-
stantial disability, diminished quality of life, impaired
physical, social and occupational functioning [2], and
poses a challenging treatment problem.
Clinical experience shows that in course of chronifica-
tion such pathophysiologically distinct conditions as
migraine and tension-type headache (TTH) tend to show
increasing clinical similarity. This could be due to a
common mechanism contributing to headache chronicity.
Two basic mechanisms have been suggested to underlie
chronification of different headache types—sensitization of
nociceptive structures and deficiency of antinociceptive
systems.
Sensitization is the process whereby the stimulus needed
to generate a response decreases over time, while the
amplitude of the response to any given stimulus increases
[3]. In migraine, central sensitization (CS) is described in
the spinal trigeminal nucleus, which receives convergent
input from the dura and the face [4, 5]. Pain arising from
innocuous stimulation of the skin is known as allodynia,
which is currently considered a clinical correlate of CS [4,
6, 7]. In fact, many patients report sensitivity to shaving,
hair brushing, wearing glasses and jewelry during a
migraine attack. In TTH, several lines of evidence indicate
that the development of sensitization at the level of the
spinal dorsal horn/trigeminal nucleus is the result of pro-
longed continuous painful input from pericranial
myofascial tissues [8]. In episodic migraine (EM) and
episodic tension-type headache CS has been thoroughly
studied [4, 7, 9], while the evidence of CS in chronic
headaches is still scarce [8, 10–12].
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Various methods have been employed to study CS—
quantitative sensory testing to assess heat and cold pain
thresholds [7], von Frey filaments [10, 12] and pressure
pain thresholds (PPT) [13] for mechanical allodynia.
Electrically elicited blink (BR) and nociceptive flexion
reflexes (NFR) have been extensively used to assess pain
sensitivity [14, 15]. The BR R3 component is thought to
follow a medullar pathway involving trigeminal circuits.
The NFR R3 threshold reduction has been accepted as
evidence of antinociceptive deficiency. There are certain
difficulties in interpreting the results obtained, as pain
sensitivity is assessed by various techniques which diag-
nostic value has not been compared.
The objective of this study was to investigate CS in
chronic headache with a variety of methods and compare
this phenomenon across chronic migraine (CM) and
chronic tension-type headache (CTTH).
Methods
The study was approved by the local ethics committee of
Sechenov Moscow Medical Academy and was performed
in accordance with the ethical standards of the 1964 Dec-
laration of Helsinki. All participants signed a document of
informed consent prior to their inclusion in the study.
A total of 69 patients with IHS-defined CM, CTTH [16]
or mixed chronic headache were recruited from the Alex-
ander Vein Headache Clinic or were referred from
municipal outpatient clinics. Control subjects were rela-
tives of patients with no appreciable headache problem
recruited from the clinic’s waiting room. Control subjects
were used rather than normative data because it was unli-
kely that the conditions of the normative trials could be
exactly reproduced, and it has been suggested that nor-
mative data in pain threshold testing may not be reliable in
different study populations [17].
Exclusion criteria for all groups were age under 18 or
over 65, the presence of peripheral neuropathy, dermato-
logical disease, chronic pain in another location, major
psychiatric disorder. All participants were not allowed to
be on headache-preventive medications (all preventives
had to be discontinued at least 3 months prior to the study)
or take rescue medications within 6 h before the exami-
nation. All patients were studied during their mildest
headaches (the pain intensity range was 0–5 cm on the 10-
cm visual analogue scale (VAS), with the mean intensity of
2.3 cm).
A questionnaire of demographic data, headache history
and clinical features was administered. In addition, an
allodynia questionnaire proposed by LoPinto et al. [12] and
the Hospital Anxiety and Depression scale (HADS) were
administered.
All assessments were carried out by one investigator.
Pressure allodynia (PA) was tested by using a pressure
algometer in five bilateral skin areas on the head and neck
(forehead V1, temple, parietal area, posterior neck/C2,
shoulder/trapezius) (Fig. 1). PPT is defined as the amount
of pressure required to change a sensation of pressure to a
sensation of pressure and pain [18]. A hand-held pressure
algometer (Commander AlgometerTM, JTech) was used.
The device displays values in lb/cm2, ranging from 0 to 20
lb, with 0.1 lb intervals. PA was also tested by using a
mechanical pinprick stimulator (Neuropen, Owen Mum-
ford) which allows exerting a quantifiable force of 40 g in
the same skin areas. The degree of pain or unpleasant
sensation upon stimulation was measured using a 100-mm
VAS. For both tests, two consecutive measurements in
each point with intervals of 20 s were obtained. The mean
score was used for further analysis.
The wind-up phenomenon (temporal summation of
pain) was induced by a pinprick followed by a train of 10
pinpricks applied repeatedly at 1 Hz on a skin area of 1 cm2
on the forehead, temple and neck with the Neuropen
stimulator. All participants assessed the intensity of pain
induced by a single pinprick and the whole train of stimuli
using the 100-mm VAS scale. Wind-up ratio was calcu-
lated as VAS (train of stimuli)/VAS (initial single
pinprick).
An algometry score was determined as the sum of
pressure pain thresholds at all sites. Pinprick and wind-up
scores were calculated similarly.
Forty patients with chronic headache and all control
subjects underwent BR and NFR testing.
Fig. 1 Skin areas of pressure algometry, pinprick and wind-up
testing
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BR: Electromyography (EMG) signals were recorded on
the right side from the orbicularis oculi muscles with a
surface electrode attached to the outer-lower eyelid. Ref-
erence electrode was attached on the nose dorsum and a
ground electrode was attached to the wrist. BR was elicited
by electrical stimulation of the right supraorbital nerve
delivered via 5-mm diameter surface electrodes. The
cathode was placed over the supraorbital foramen and the
anode was placed approximately 1 cm rostrally on the
forehead. The stimulation consisted of 0.2 ms rectangular
single pulses delivered with arbitrary intervals of not less
than 30 s to minimize habituation. EMG signals were
amplified by biopotential amplifiers (Keypoint Portable,
Medtronic) with the bandwidth of 10 Hz–5 kHz. We ana-
lyzed the thresholds of the ultralate R3 component,
probably following a multisynaptic trigeminal pathway in
the medullar reticular formation involving antinociceptive
structures such as periaqueductal gray and raphe nuclei
[19]. Ellrich et al. [20] showed that cutaneous A-beta and
A-delta fibres constitute the generators of the electrically
elicited R3 component.
NFR: The surface stimulating electrodes were placed at
a retromalleolar location along the course of the right sural
nerve, 2 cm apart, with the cathode placed proximally. The
recording surface electrodes were placed on the tendon
(reference electrode) and over the belly of the biceps
femoris capitis brevis muscle (active electrode). The
stimulus consisted of pulse trains of 20 ms duration, with
an interval frequency of 300 Hz and arbitrary intervals of
not less than 15 s. EMG signals were amplified by biopo-
tential amplifiers (Keypoint Portable, Medtronic) with the
bandwidth of 20 Hz–5 kHz. We registered the R3 (reflex)
threshold and the subjective pain threshold.
Data were analyzed using Statistica software (Mann–
Whitney U test for between-group comparisons, Wilcoxon
test to assess side-to-side differences, Spearman correla-
tions, Fisher’s exact test to compare proportions). All
values are shown as mean ± standard deviation (SD).
Results
Patient demographics and clinical features of chronic
headache
The headache group included 25 patients with CM, 25
patients with CTTH and 19 patients with mixed chronic
headache (CM or CTTH plus cervicogenic headache),
according to ICHD-2 [16]. Mean headache frequency was
25 days per month with the mean pain intensity of 7 cm.
With an average 18-year headache history, our patients
reported having chronic headache for 6 years. Analgesic
overuse was present in 20 (29%) patients. When filling the
allodynia questionnaire, patients were asked to give a
positive response if allodynia was present at any moment—
during the baseline headache, its exacerbations or both.
Based on the questionnaire, the prevalence of cutaneous
allodynia was 79%. Our patients reported low depression
(7 points) and mild anxiety levels (10 points) (Table 1).
Pain sensitivity in chronic headache
Pressure pain sensitivity was consistently higher among
headache patients than among controls across all sites
except temples, pinprick pain and wind-up ratios—across
all sites except the forehead. In the CM subgroup, no dif-
ferences in any measured parameters were observed
between the predominant side of pain and the contralateral
side.
In the headache group significant reduction of the
algometry and increase of the pinprick scores were
observed (P = 0.004 and P = 0.0008, respectively), com-
pared with controls. In the headache group, we also found
significant reduction of the BR R3 threshold (7.6 ± 2.16 vs.
9.6 ± 1.5 mA), NFR R3 threshold (9.0 ± 2.2 vs. 10.3 ± 1.7
mA) and NFR pain threshold (6.2 ± 1.9 vs. 9.8 ± 1.8 mA)
(Table 2).
As there are no standard cut-off values for allodynia in
algometry, we used the control group to define PA. To
classify a subject’s response as allodynic, the cut-off value
for allodynia was defined as the algometry score level,
above which 95% of control subjects responded. This cut-
off value was 41.9 lb. Based on this score, the prevalence
of pressure allodynia in the headache group was 70%.
Based on the pinprick score, allodynia prevalence was
58%, while based on both algometry and pinprick scores,
79.7%.
To compare the diagnostic value of the simple pressure
algometry technique coupled with a wind-up assessment
Table 1 Patient demographics and clinical features of chronic
headache
Headache Control
Group size 69 18
Gender (female:male) 57:12 13:5
Age (years) 40.1 ± 12.3 43.1 ± 18.1
Headache frequency (days/month) 25.2 ± 6.0
Pain intensity (VAS) 7.1 ± 1.9
Headache history (years) 18.2 ± 12.7
Chronic headache history (years) 5.7 ± 7.0
Cutaneous allodynia 79%
Depression 7.4 ± 3.5
Anxiety 9.7 ± 3.9
Pain intensity at exam (VAS) 2.3 ± 1.9 0
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and a more sophisticated and time-consuming BR or NFR
testing, we defined the cut-off values for BR and NFR R3
thresholds as described above. These cut-off values were
8.9 mA for the BR R3 and 9.45 mA for the NFR R3
threshold. Based on these cut-off values, the prevalence of
CS was 76% as defined by BR and 62% by NFR. The
diagnostic sensitivity of the algometry + wind-up combi-
nation (allodynia was considered present if at least one
method yielded a positive result) differed neither from BR
nor from NFR (McNemar’s test, P = 1.0).
No correlations between such clinical characteristics as
headache frequency, chronic or total headache history and
pain sensitivity parameters were observed.
Comparison of clinical headache characteristics and
allodynia between CM and CTTH
For comparison across headache types, 25 patients with
CM and 25 patients with CTTH were enrolled. Both
headache groups were comparable from the demographical
and clinical perspective. Patients with CM (68%) and with
CTTH (64%) reported symptoms of cutaneous allodynia
(Table 3).
No significant difference in any of the pain sensitivity
parameters was observed between CM and CTTH (Fig. 2).
The prevalence of PA was 60% in the CM group and
68% in the CTTH group (no between-group differences,
Fisher’s exact test, P = 0.7).
Discussion
This study presents a comprehensive analysis of CS in
patients with chronic headaches during their mildest pain
and uses various methods—pressure algometry, pinprick
and wind-up assessments and more sophisticated neuro-
physiologic techniques. In addition, the study features a
comparative analysis of CS across different types of
chronic headache.
Our study has shown that patients with chronic headache
exhibit both pressure and pinprick allodynia, and increased
temporal summation of pain. Our data is in keeping with
other authors reporting reduced pressure pain thresholds as
evidence of CS [13, 21]. Wind-up has been suggested to be
responsible for the induction and maintenance of central
sensitization. Although it is not equivalent to CS, it is a
progressive, frequency-dependent increase in C-fibre
evoked responses of trigeminal and spinal dorsal WDR
neurons [22].
In chronic headaches, CS can be stably detected during
the baseline headache and even in the headache-free per-
iod. In our study, allodynia prevalence was 79% based on
the allodynia questionnaire, 70% based on the pressure
pain testing and 79.7% based on pressure and pinprick pain
testing. Cooke et al. [10] who assessed pain sensitivity with
von Frey filaments reported a 75% prevalence. Our data is
also in keeping with Burstein et al. [4] who defined allo-
dynia thresholds in mechanical, heat and cold sensory tests
and achieved a higher sensitivity for detection of allodynia
by testing three allodynia modalities.
Burstein et al. [7] showed that during the migraine
attack cutaneous allodynia develops on the pain side and
spreads to the contralateral side only in prolonged attacks.
At the same time, our study has demonstrated that patients
with chronic headaches exhibit bilateral CS, which is
unrelated to the predominant side of pain during exacer-
bations. Absence of side-to-side differences was also
reported in CTTH [13]. These findings suggest that CS is
stable and permanent in chronic headaches. Yet, in EM,
allodynia has been shown to be less persistent and less
prominent and temporarily related to migraine attacks.
Having evolved to a daily or near-daily pattern, pain
becomes independent from specific triggers and is sus-
tained by the stable CS of nociceptive structures.
As there are no correlations between CS and the length
of headache history, factors other than duration might
Table 2 Pain sensitivity in chronic headache
Headache Control Group
differences
Algometry score 40.64 ± 13.4 52.5 ± 16.7 P \ 0.005*
Pinprick score 54.76 ± 62.9 19.08 ± 21.6 P \ 0.005*
Wind-up score 24.07 ± 24.37 12.4 ± 8.3 NS
BR R3 (mA) 7.6 ± 2.16 9.6 ± 1.5 P \ 0.0001*
NFR R3 (mA) 9.0 ± 2.2 10.3 ± 1.7 P \ 0.005*
NFR pain threshold
(mA)
6.2 ± 1.9 9.8 ± 1.8 P \ 0.0001*
* Significant differences
NS not significant
Table 3 Patient demographics and clinical features of CM and
CTTH
CM CTTH
Group size 25 25
Gender (female:male) 23:2 23:2
Age (years) 44.5 ± 12.6 39.5 ± 10.0
Headache frequency (days/month) 23.5 ± 6.2 25.1 ± 6.0
Pain intensity (VAS)* 8.7 ± 1.4 6.2 ± 1.6
Chronic headache history (years) 6.6 ± 7.5 4.8 ± 6.0
Cutaneous allodynia (%) 68 64
Depression 6.5 ± 4.0 7.6 ± 3.2
Anxiety 9.5 ± 4.7 10.9 ± 3.5
Pain intensity at exam (VAS) 2.44 ± 2.3 2.52 ± 1.9
* Significant difference
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contribute to its chronification. Clinical evidence shows
that some patients report having episodic headaches for
years, others, vice versa, rather quickly progress towards
frequent and transformed headache patterns. This means
that clinicians need to examine headache patients thor-
oughly to detect the first signs of CS even in patients with
short headache history. The presence of allodynia may
support decisions to undertake early and aggressive pre-
ventive treatment in patients with episodic headache
presenting with CS in the headache-free period.
Anxiety and depression have been suggested to con-
tribute to headache chronification and share similar
neurobiological mechanisms [23]. Our patients reported
subclinical levels of depression and anxiety.
Anecdotal evidence shows that triptan efficacy is
markedly reduced in CM. Burstein et al. [24] provided
convincing evidence for the 2-h time window for triptans,
i.e. they should be administered during the period of
peripheral sensitization, before cutaneous allodynia devel-
ops. This may be, however, a challenge for patients with
chronic headaches, as very often pain is continuous and
cutaneous allodynia is detected already during the mild
headache and even in the pain-free period. In this light, CS
appears to underlie intractable headaches.
This study has also shown no differences in allodynia
levels between CM and CTTT. These data are in line with
the clinical evidence showing that once the process of
chronification is underway, such clinically distinct disor-
ders as migraine and tension-type headache tend to show
increasing clinical similarity. This means that persistent
CS, detected during baseline headache, may reflect a
common pathological mechanism of headache chronifica-
tion and chronicity maintaining.
The reduced BR and NFR R3 thresholds we observed
are in keeping with other studies [14]. The R3 component
has been shown to be nociceptive in origin [25], as it
appears after low intensity and potentially not dangerous
stimuli and is markedly reduced by anesthetic block. R3
could be interpreted as an expression of a possible primary
dysfunction of the trigeminal reflex circuits probably
caused by a failure of central control on the brainstem
neuronal networks [26]. The incoming nociceptive impul-
ses converging on the trigeminal nucleus caudalis result in
pain summation (wind-up), a decrease in activation
threshold (CS), a parallel decrease in headache attack
threshold and, finally, headache chronification [25].
However, very recently Ellrich et al. [20] showed that
cutaneous A-beta and A-delta, but not C-fibres constitute
the generators of the electrically elicited R3 component.
One of the limitations of this study is the recording of BR
by using the standard stimulus electrode. The ‘nociceptive’
BR (nBR) is possible to elicit by a custom-built planar
concentric electrode providing a high current density at low
intensities via a central cathode of 1 mm2 [27]. While some
authors note that R3 abnormalities detected in migraine
may be ascribed to a general dysfunction of adaptation
capacity to environmental conditions [28], nBR may be a
more suitable method for CS research once the electrodes
become commercially available.
While BR testing yields results similar to other tech-
niques, and A-delta fibres are involved in the mediation of
the R3 component, reduced R3 thresholds probably reflect
CS in the trigeminal circuits and may be a reliable measure
of CS.
NFRs are related to A-delta fibre activation. Reduced
NFR thresholds have led many authors to conclude that
chronic headache is a disorder of endogenous antinoci-
ceptive systems [15, 29]. Impairment of endogenous
supraspinal pain modulation systems opens up the way for
CS in the spinal trigeminal nucleus.
In our study, allodynia was assessed using a variety of
techniques. Although there is uncertainty about the diag-
nostic sensitivity of these methods, we showed that
simultaneous usage of a whole battery of techniques might
improve their sensitivity in the detection of CS. Our study
has shown similar prevalence of allodynia as detected by
each method. Moreover, our results are in line with the
previous reports on CS in headaches [4, 10, 14, 21, 29]. As
these methods give comparable results, in the tight periods
of a consultation neurologists can use such simple and time
efficient methods as pressure algometry and wind-up test-
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Fig. 2 Non-significant
differences in algometry,
pinprick and wind-up scores,
BR R3, NFR R3 and NFR pain
thresholds between CM (striped
bars) and CTTH (full bars)
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Future studies of CS in chronic headaches are required,
as deeper understanding of this phenomenon may shed
light on the mechanisms of headache chronification, causes
of its intractability, as well as provide a firm basis for novel
pathogenesis-based methods of treatment.
This comprehensive study shows that most patients with
chronic headache exhibit CS during baseline headache
detectable by various techniques. CS level does not depend
on such clinical headache characteristics as frequency,
duration or predominant side of pain. Neither are CS
prevalence and level related to the headache form, sug-
gesting that CS may be a universal mechanism of headache
chronification and chronicity maintaining.
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